Aptevo Therapeutics Stock Technical Analysis

APVO Stock  USD 0.77  0.06  8.45%   
As of the 18th of April 2024, Aptevo Therapeutics shows the Risk Adjusted Performance of (0.15), mean deviation of 6.96, and Standard Deviation of 10.75. Aptevo Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Aptevo Therapeutics, which can be compared to its peers. Please confirm Aptevo Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Aptevo Therapeutics is priced correctly, providing market reflects its regular price of 0.77 per share. As Aptevo Therapeutics is a penny stock we also strongly suggest to validate its jensen alpha numbers.

Aptevo Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Aptevo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Aptevo
  
Aptevo Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Aptevo Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
8.38Strong Buy2Odds
Aptevo Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Aptevo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aptevo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aptevo Therapeutics, talking to its executives and customers, or listening to Aptevo conference calls.
Aptevo Analyst Advice Details
Aptevo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aptevo Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aptevo Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Aptevo Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Aptevo Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Aptevo Therapeutics Trend Analysis

Use this graph to draw trend lines for Aptevo Therapeutics. You can use it to identify possible trend reversals for Aptevo Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Aptevo Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Aptevo Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Aptevo Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.1  , which may suggest that Aptevo Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 344.35, which is the sum of squared deviations for the predicted Aptevo Therapeutics price change compared to its average price change.

About Aptevo Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Aptevo Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Aptevo Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Aptevo Therapeutics price pattern first instead of the macroeconomic environment surrounding Aptevo Therapeutics. By analyzing Aptevo Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Aptevo Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Aptevo Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Dividend Yield0.283.38E-43.04E-42.89E-4
Price To Sales Ratio3.03.84.374.15

Aptevo Therapeutics April 18, 2024 Technical Indicators

Most technical analysis of Aptevo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aptevo from various momentum indicators to cycle indicators. When you analyze Aptevo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Aptevo Therapeutics April 18, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Aptevo stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Aptevo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptevo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptevo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptevo Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptevo Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Aptevo Stock analysis

When running Aptevo Therapeutics' price analysis, check to measure Aptevo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptevo Therapeutics is operating at the current time. Most of Aptevo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aptevo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptevo Therapeutics' price. Additionally, you may evaluate how the addition of Aptevo Therapeutics to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Aptevo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(67.07)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.61)
Return On Equity
(1.24)
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.